Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Search type
Keyword
Author
Edition
European
US
Diabetes
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
AI-led Diabetes Prevention Programme Proves Unsatisfying for Patients
August 2026
AI-led diabetes prevention drove faster engagement than human coaching, but patients rated it lower on satisfaction.
Read more
18 Aug 2026
AI-led Diabetes Prevention Programme Proves Unsatisfying for Patients
AI-led diabetes prevention drove faster engagement than human coaching, but patients rated it lower on satisfaction.
15 Aug 2026
Sleeve Gastrectomy More Effective Than GLP-1 Drugs for Weight Loss
Sleeve gastrectomy was more effective than GLP-1 drugs for weight loss and glycaemic control after one year.
13 Aug 2026
Tirzepatide GLP-1 Linked to Lower Risk of Cardiovascular Events
A study showed that the GLP-1 drug Tirzepatide has been associated with a lower risk of major adverse cardiovascular events compared with alternative treatment.
11 Aug 2026
UK Approves New Treatment for Weight Loss and Diabetes
The UK has approved Eli Lilly’s Foundayo GLP-1 pill for weight loss and type 2 diabetes.
11 Aug 2026
GRHL2 May Drive Diabetic Foot Ulcer Repair
NPWT activated GRHL2 and promoted cell conversion in diabetic foot ulcers, revealing a potential mechanism underlying wound repair.
8 Aug 2026
Probiotic Improved Type 2 Diabetes Markers
L. plantarum LH36 improved type 2 diabetes markers, gut microbiota, and metabolic profiles in a mouse model.
6 Aug 2026
New Report Urges Better Diabetes Support Across England
National review of diabetes services found significant variation in outcomes, health checks, technology uptake, and transition support for children and young adults.
4 Aug 2026
Protein Breakfast Offset Genetic Glucose Response Risk
A randomised crossover trial found that individuals with the MTNR1B GG genotype had a greater glucose response to a carbohydrate rich breakfast, while a protein enriched breakfast eliminated significant genotype differences.
Loading posts...
1
2
3
…
52
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View